EVRYSDI
Powder for oral solution, 0.75mg/ml
RestrictedActive license
Active substance (INN)
risdiplam
Pharmaceutical form
Pharmaceutical formPowder for oral solution
Strength0.75mg/ml
PackagingUkupno 1 boca sa praškom za oralni rastvor u kartonskoj kutiji
ManufacturerF.Hoffmann-La Roche Ltd., Switzerland
Therapeutic groupMusculo-skeletal system (M09AX10)
Marketing authorization holder"Hoffmann-La Roche LTD" D.S.D. Podgorica
Authorization dateJune 20, 2022
Source: CInMED register